Global Molecular Diagnostics Market (2016 - 2022)

Name: Global Molecular Diagnostics Market (2016 - 2022)
Brand: KBV Research
SKU: GD8AE6ACB5AEN
Price: 3600 USD
Availability: InStock

February 2017 | 422 pages | ID: GD8AE6ACB5AEN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

The key driving factors for molecular diagnostics market are high prevalence of infectious diseases and adoption of personalized medicines & companion diagnostics. Additionally, advanced diagnostics technologies and increase in the number of cancer diagnostics are some of the other factors leading the market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers.

Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Region, market is segmented into North America, Europe, Asia- Pacific and LAMEA (Latin America, Middle East and Africa). North America is expected to dominate the market growth owing to the increase in the number of infectious diseases. Unhealthy lifestyle and infectious diseases is becoming the major concern worldwide. According to the data estimated by Centers for Diseases Control and Prevention (CDC), number of deaths due to cancer estimated was 591,699 and Chronic lower respiratory diseases was 147,101. Additionally, According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. Hence, it could be expected that Asia Pacific and other regions would be contributing in the growth of molecular diagnostics market.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.

CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Molecular Diagnostics Market, by Product & Services
  1.4.2 Global Molecular Diagnostics Market, by Technology
  1.4.3 Global Molecular Diagnostics Market, by Application
  1.4.4 Global Molecular Diagnostics Market, by End User
  1.4.5 Global Molecular Diagnostics Market, by Geography
1.5 Methodology for the research

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. MARKET OVERVIEW

3.1 Introduction
3.2 Drivers, Restraints and Opportunities
  3.2.1 Market Drivers
  3.2.2 Market Restraints

CHAPTER 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET

4.1 Global Molecular Diagnostics Market by Product & Services
  4.1.1 Global Molecular Diagnostics Reagents & Kits Market by Region
  4.1.2 Global Molecular Diagnostics Instruments Market by Region
  4.1.3 Global Molecular Diagnostics Software & Services Market by Region

CHAPTER 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY

5.1 Introduction
  5.1.1 Global Polymerase Chain Reaction Molecular Diagnostics Market by Region
  5.1.2 Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Region
  5.1.3 Global Hybridization Molecular Diagnostics Market by Region
  5.1.4 Global DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Region
  5.1.5 Global Microarray Molecular Diagnostics Market by Region
  5.1.6 Global Other Technologies Market by Region

CHAPTER 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION

6.1 Introduction
  6.1.1 Global Infectious Diseases Molecular Diagnostics Market by Region
  6.1.2 Global Infectious Diseases Molecular Diagnostics Market by Type
    6.1.2.1 Global Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Region
    6.1.2.2 Global Hepatitis B & Hepatitis C Molecular Diagnostics Market by Region
    6.1.2.3 Global Human Papillomavirus Molecular Diagnostics Market by Region
    6.1.2.4 Global Human Immunodeficiency Virus Molecular Diagnostics Market by Region
    6.1.2.5 Global Tuberculosis Molecular Diagnostics Market by Region
    6.1.2.6 Global Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Region
    6.1.2.7 Global Molecular Diagnostics in Other Infectious Diseases Market by Region
  6.1.3 Global Oncology Molecular Diagnostics Market by Region
  6.1.4 Global Oncology Molecular Diagnostics Market by Type
    6.1.4.1 Global Breast Cancer Molecular Diagnostics Market by Region
    6.1.4.2 Global Colorectal Cancer Molecular Diagnostics Market by Region
    6.1.4.3 Global Prostate Cancer Molecular Diagnostics Market by Region
    6.1.4.4 Global Other Cancers Molecular Diagnostics Market by Region
  6.1.5 Global Blood Screening Molecular Diagnostics Market by Region
  6.1.6 Global Genetic Tests Molecular Diagnostics Market by Region
  6.1.7 Global Microbiology Molecular Diagnostics Market by Region
  6.1.8 Global Other Applications Market by Region

CHAPTER 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER

7.1 Introduction
  7.1.1 Global Molecular Diagnostics Market for Hospital & Academic Laboratories by Region
  7.1.2 Global Molecular Diagnostics Market for Reference Laboratories by Region
  7.1.3 Global Molecular Diagnostics Market for Other End Users by Region

CHAPTER 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION

8.1 Introduction
8.2 North America Molecular Diagnostics Market
  8.2.1 North America Molecular Diagnostics Market by Product & Services
    8.2.1.1 North America Molecular Diagnostics Reagents & Kits Market by Country
    8.2.1.2 North America Molecular Diagnostics Instruments Market by Country
    8.2.1.3 North America Molecular Diagnostics Software & Services Market by Country
  8.2.2 North America Molecular Diagnostics Market by Technology
    8.2.2.1 North America Polymerase Chain Reaction Molecular Diagnostics Market by Country
    8.2.2.2 North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
    8.2.2.3 North America Hybridization Molecular Diagnostics Market by Country
    8.2.2.4 North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
    8.2.2.5 North America Microarray Molecular Diagnostics Market by Country
    8.2.2.6 North America Other Technologies Market by Country
  8.2.3 North America Molecular Diagnostics Market by Application
    8.2.3.1 North America Infectious Diseases Molecular Diagnostics Market by Country
    8.2.3.2 North America Infectious Diseases Molecular Diagnostics Market by Type
      8.2.3.2.1 North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
      8.2.3.2.2 North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
      8.2.3.2.3 North America Human Papillomavirus Molecular Diagnostics Market by Country
      8.2.3.2.4 North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country
      8.2.3.2.5 North America Tuberculosis Molecular Diagnostics Market by Country
      8.2.3.2.6 North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
      8.2.3.2.7 North America Molecular Diagnostics in Other Infectious Diseases Market by Country
    8.2.3.3 North America Oncology Molecular Diagnostics Market by Country
    8.2.3.4 North America Oncology Molecular Diagnostics Market by Type
      8.2.3.4.1 North America Breast Cancer Molecular Diagnostics Market by Country
      8.2.3.4.2 North America Colorectal Cancer Molecular Diagnostics Market by Country
      8.2.3.4.3 North America Prostate Cancer Molecular Diagnostics Market by Country
      8.2.3.4.4 North America Other Cancers Molecular Diagnostics Market by Country
    8.2.3.5 North America Blood Screening Molecular Diagnostics Market by Country
    8.2.3.6 North America Genetic Tests Molecular Diagnostics Market by Country
    8.2.3.7 North America Microbiology Molecular Diagnostics Market by Country
    8.2.3.8 North America Other Applications Market by Country
  8.2.4 North America Molecular Diagnostics Market by End User
    8.2.4.1 North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
    8.2.4.2 North America Molecular Diagnostics Market for Reference Laboratories by Country
    8.2.4.3 North America Molecular Diagnostics Market for Other End Users by Country
  8.2.5 North America Molecular Diagnostics Market by Country
    8.2.5.1 US Molecular Diagnostics Market
      8.2.5.1.1 US Molecular Diagnostics Market by Product & Services
      8.2.5.1.2 US Molecular Diagnostics Market by Technology
      8.2.5.1.3 US Molecular Diagnostics Market by Application
      8.2.5.1.4 US Molecular Diagnostics Market by End User
    8.2.5.2 Canada Molecular Diagnostics Market
      8.2.5.2.1 Canada Molecular Diagnostics Market by Product & Services
      8.2.5.2.2 Canada Molecular Diagnostics Market by Technology
      8.2.5.2.3 Canada Molecular Diagnostics Market by Application
      8.2.5.2.4 Canada Molecular Diagnostics Market by End User
    8.2.5.3 Mexico Molecular Diagnostics Market
      8.2.5.3.1 Mexico Molecular Diagnostics Market by Product & Services
      8.2.5.3.2 Mexico Molecular Diagnostics Market by Technology
      8.2.5.3.3 Mexico Molecular Diagnostics Market by Application
      8.2.5.3.4 Mexico Molecular Diagnostics Market by End User
    8.2.5.4 Rest of North America Molecular Diagnostics Market
      8.2.5.4.1 Rest of North America Molecular Diagnostics Market by Product & Services
      8.2.5.4.2 Rest of North America Molecular Diagnostics Market by Technology
      8.2.5.4.3 Rest of North America Molecular Diagnostics Market by Application
      8.2.5.4.4 Rest of North America Molecular Diagnostics Market by End User
8.3 Europe Molecular Diagnostics Market
  8.3.1 Europe Molecular Diagnostics Market by Product & Services
    8.3.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
    8.3.1.2 Europe Molecular Diagnostics Instruments Market by Country
    8.3.1.3 Europe Molecular Diagnostics Software & Services Market by Country
  8.3.2 Europe Molecular Diagnostics Market by Technology
    8.3.2.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
    8.3.2.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
    8.3.2.3 Europe Hybridization Molecular Diagnostics Market by Country
    8.3.2.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
    8.3.2.5 Europe Microarray Molecular Diagnostics Market by Country
    8.3.2.6 Europe Other Technologies Market by Country
  8.3.3 Europe Molecular Diagnostics Market by Application
    8.3.3.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
    8.3.3.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
      8.3.3.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
      8.3.3.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
      8.3.3.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
      8.3.3.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
      8.3.3.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
      8.3.3.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
      8.3.3.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
    8.3.3.3 Europe Oncology Molecular Diagnostics Market by Country
    8.3.3.4 Europe Oncology Molecular Diagnostics Market by Type
      8.3.3.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
      8.3.3.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
      8.3.3.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
      8.3.3.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
    8.3.3.5 Europe Blood Screening Molecular Diagnostics Market by Country
    8.3.3.6 Europe Genetic Tests Molecular Diagnostics Market by Country
    8.3.3.7 Europe Microbiology Molecular Diagnostics Market by Country
    8.3.3.8 Europe Other Applications Market by Country
  8.3.4 Europe Molecular Diagnostics Market by End User
    8.3.4.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
    8.3.4.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
    8.3.4.3 Europe Molecular Diagnostics Market for Other End Users by Country
  8.3.5 Europe Molecular Diagnostics Market by Country
    8.3.5.1 Germany Molecular Diagnostics Market
      8.3.5.1.1 Germany Molecular Diagnostics Market by Product & Services
      8.3.5.1.2 Germany Molecular Diagnostics Market by Technology
      8.3.5.1.3 Germany Molecular Diagnostics Market by Application
      8.3.5.1.4 Germany Molecular Diagnostics Market by End User
    8.3.5.2 UK Molecular Diagnostics Market
      8.3.5.2.1 UK Molecular Diagnostics Market by Product & Services
      8.3.5.2.2 UK Molecular Diagnostics Market by Technology
      8.3.5.2.3 UK Molecular Diagnostics Market by Application
      8.3.5.2.4 UK Molecular Diagnostics Market by End User
    8.3.5.3 France Molecular Diagnostics Market
      8.3.5.3.1 France Molecular Diagnostics Market by Product & Services
      8.3.5.3.2 France Molecular Diagnostics Market by Technology
      8.3.5.3.3 France Molecular Diagnostics Market by Application
      8.3.5.3.4 France Molecular Diagnostics Market by End User
    8.3.5.4 Russia Molecular Diagnostics Market
      8.3.5.4.1 Russia Molecular Diagnostics Market by Product & Services
      8.3.5.4.2 Russia Molecular Diagnostics Market by Technology
      8.3.5.4.3 Russia Molecular Diagnostics Market by Application
      8.3.5.4.4 Russia Molecular Diagnostics Market by End User
    8.3.5.5 Spain Molecular Diagnostics Market
      8.3.5.5.1 Spain Molecular Diagnostics Market by Product & Services
      8.3.5.5.2 Spain Molecular Diagnostics Market by Technology
      8.3.5.5.3 Spain Molecular Diagnostics Market by Application
      8.3.5.5.4 Spain Molecular Diagnostics Market by End User
    8.3.5.6 Italy Molecular Diagnostics Market
      8.3.5.6.1 Italy Molecular Diagnostics Market by Product & Services
      8.3.5.6.2 Italy Molecular Diagnostics Market by Technology
      8.3.5.6.3 Italy Molecular Diagnostics Market by Application
      8.3.5.6.4 Italy Molecular Diagnostics Market by End User
    8.3.5.7 Rest of Europe Molecular Diagnostics Market
      8.3.5.7.1 Rest of Europe Molecular Diagnostics Market by Product & Services
      8.3.5.7.2 Rest of Europe Molecular Diagnostics Market by Technology
      8.3.5.7.3 Rest of Europe Molecular Diagnostics Market by Application
      8.3.5.7.4 Rest of Europe Molecular Diagnostics Market by End User
8.4 Asia-Pacific Molecular Diagnostics Market
  8.4.1 Asia-Pacific Molecular Diagnostics Market by Product & Services
    8.4.1.1 Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country
    8.4.1.2 Asia-Pacific Molecular Diagnostics Instruments Market by Country
    8.4.1.3 Asia-Pacific Molecular Diagnostics Software & Services Market by Country
  8.4.2 Asia-Pacific Molecular Diagnostics Market by Technology
    8.4.2.1 Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country
    8.4.2.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
    8.4.2.3 Asia-Pacific Hybridization Molecular Diagnostics Market by Country
    8.4.2.4 Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
    8.4.2.5 Asia-Pacific Microarray Molecular Diagnostics Market by Country
    8.4.2.6 Asia-Pacific Other Technologies Market by Country
  8.4.3 Asia-Pacific Molecular Diagnostics Market by Application
    8.4.3.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country
    8.4.3.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
      8.4.3.2.1 Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
      8.4.3.2.2 Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
      8.4.3.2.3 Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country
      8.4.3.2.4 Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country
      8.4.3.2.5 Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country
      8.4.3.2.6 Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
      8.4.3.2.7 Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country
    8.4.3.3 Asia-Pacific Oncology Molecular Diagnostics Market by Country
    8.4.3.4 Asia-Pacific Oncology Molecular Diagnostics Market by Type
      8.4.3.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country
      8.4.3.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country
      8.4.3.4.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country
      8.4.3.4.4 Asia-Pacific Other Cancers Molecular Diagnostics Market by Country
    8.4.3.5 Asia-Pacific Blood Screening Molecular Diagnostics Market by Country
    8.4.3.6 Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country
    8.4.3.7 Asia-Pacific Microbiology Molecular Diagnostics Market by Country
    8.4.3.8 Asia-Pacific Other Applications Market by Country
  8.4.4 Asia-Pacific Molecular Diagnostics Market by End User
    8.4.4.1 Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
    8.4.4.2 Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country
    8.4.4.3 Asia-Pacific Molecular Diagnostics Market for Other End Users by Country
  8.4.5 Asia-Pacific Molecular Diagnostics Market by Country
    8.4.5.1 China Molecular Diagnostics Market
      8.4.5.1.1 China Molecular Diagnostics Market by Product & Services
      8.4.5.1.2 China Molecular Diagnostics Market by Technology
      8.4.5.1.3 China Molecular Diagnostics Market by Application
      8.4.5.1.4 China Molecular Diagnostics Market by End User
    8.4.5.2 Japan Molecular Diagnostics Market
      8.4.5.2.1 Japan Molecular Diagnostics Market by Product & Services
      8.4.5.2.2 Japan Molecular Diagnostics Market by Technology
      8.4.5.2.3 Japan Molecular Diagnostics Market by Application
      8.4.5.2.4 Japan Molecular Diagnostics Market by End User
    8.4.5.3 India Molecular Diagnostics Market
      8.4.5.3.1 India Molecular Diagnostics Market by Product & Services
      8.4.5.3.2 India Molecular Diagnostics Market by Technology
      8.4.5.3.3 India Molecular Diagnostics Market by Application
      8.4.5.3.4 India Molecular Diagnostics Market by End User
    8.4.5.4 South Korea Molecular Diagnostics Market
      8.4.5.4.1 South Korea Molecular Diagnostics Market by Product & Services
      8.4.5.4.2 South Korea Molecular Diagnostics Market by Technology
      8.4.5.4.3 South Korea Molecular Diagnostics Market by Application
      8.4.5.4.4 South Korea Molecular Diagnostics Market by End User
    8.4.5.5 Australia Molecular Diagnostics Market
      8.4.5.5.1 Australia Molecular Diagnostics Market by Product & Services
      8.4.5.5.2 Australia Molecular Diagnostics Market by Technology
      8.4.5.5.3 Australia Molecular Diagnostics Market by Application
      8.4.5.5.4 Australia Molecular Diagnostics Market by End User
    8.4.5.6 Singapore Molecular Diagnostics Market
      8.4.5.6.1 Singapore Molecular Diagnostics Market by Product & Services
      8.4.5.6.2 Singapore Molecular Diagnostics Market by Technology
      8.4.5.6.3 Singapore Molecular Diagnostics Market by Application
      8.4.5.6.4 Singapore Molecular Diagnostics Market by End User
    8.4.5.7 Rest of Asia-Pacific Molecular Diagnostics Market
      8.4.5.7.1 Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services
      8.4.5.7.2 Rest of Asia-Pacific Molecular Diagnostics Market by Technology
      8.4.5.7.3 Rest of Asia-Pacific Molecular Diagnostics Market by Application
      8.4.5.7.4 Rest of Asia-Pacific Molecular Diagnostics Market by End User
8.5 LAMEA Molecular Diagnostics Market
  8.5.1 LAMEA Molecular Diagnostics Market by Product & Services
    8.5.1.1 LAMEA Molecular Diagnostics Reagents & Kits Market by Country
    8.5.1.2 LAMEA Molecular Diagnostics Instruments Market by Country
    8.5.1.3 LAMEA Molecular Diagnostics Software & Services Market by Country
  8.5.2 LAMEA Molecular Diagnostics Market by Technology
    8.5.2.1 LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country
    8.5.2.2 LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
    8.5.2.3 LAMEA Hybridization Molecular Diagnostics Market by Country
    8.5.2.4 LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
    8.5.2.5 LAMEA Microarray Molecular Diagnostics Market by Country
    8.5.2.6 LAMEA Other Technologies Market by Country
  8.5.3 LAMEA Molecular Diagnostics Market by Application
    8.5.3.1 LAMEA Infectious Diseases Molecular Diagnostics Market by Country
    8.5.3.2 LAMEA Infectious Diseases Molecular Diagnostics Market by Type
      8.5.3.2.1 LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
      8.5.3.2.2 LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
      8.5.3.2.3 LAMEA Human Papillomavirus Molecular Diagnostics Market by Country
      8.5.3.2.4 LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country
      8.5.3.2.5 LAMEA Tuberculosis Molecular Diagnostics Market by Country
      8.5.3.2.6 LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
      8.5.3.2.7 LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country
    8.5.3.3 LAMEA Oncology Molecular Diagnostics Market by Country
    8.5.3.4 LAMEA Oncology Molecular Diagnostics Market by Type
      8.5.3.4.1 LAMEA Breast Cancer Molecular Diagnostics Market by Country
      8.5.3.4.2 LAMEA Colorectal Cancer Molecular Diagnostics Market by Country
      8.5.3.4.3 LAMEA Prostate Cancer Molecular Diagnostics Market by Country
      8.5.3.4.4 LAMEA Other Cancers Molecular Diagnostics Market by Country
    8.5.3.5 LAMEA Blood Screening Molecular Diagnostics Market by Country
    8.5.3.6 LAMEA Genetic Tests Molecular Diagnostics Market by Country
    8.5.3.7 LAMEA Microbiology Molecular Diagnostics Market by Country
    8.5.3.8 LAMEA Other Applications Market by Country
  8.5.4 LAMEA Molecular Diagnostics Market by End User
    8.5.4.1 LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
    8.5.4.2 LAMEA Molecular Diagnostics Market for Reference Laboratories by Country
    8.5.4.3 LAMEA Molecular Diagnostics Market for Other End Users by Country
  8.5.5 LAMEA Molecular Diagnostics Market by Country
    8.5.5.1 Brazil Molecular Diagnostics Market
      8.5.5.1.1 Brazil Molecular Diagnostics Market by Product & Services
      8.5.5.1.2 Brazil Molecular Diagnostics Market by Technology
      8.5.5.1.3 Brazil Molecular Diagnostics Market by Application
      8.5.5.1.4 Brazil Molecular Diagnostics Market by End User
    8.5.5.2 Argentina Molecular Diagnostics Market
      8.5.5.2.1 Argentina Molecular Diagnostics Market by Product & Services
      8.5.5.2.2 Argentina Molecular Diagnostics Market by Technology
      8.5.5.2.3 Argentina Molecular Diagnostics Market by Application
      8.5.5.2.4 Argentina Molecular Diagnostics Market by End User
    8.5.5.3 UAE Molecular Diagnostics Market
      8.5.5.3.1 UAE Molecular Diagnostics Market by Product & Services
      8.5.5.3.2 UAE Molecular Diagnostics Market by Technology
      8.5.5.3.3 UAE Molecular Diagnostics Market by Application
      8.5.5.3.4 UAE Molecular Diagnostics Market by End User
    8.5.5.4 Saudi Arabia Molecular Diagnostics Market
      8.5.5.4.1 Saudi Arabia Molecular Diagnostics Market by Product & Services
      8.5.5.4.2 Saudi Arabia Molecular Diagnostics Market by Technology
      8.5.5.4.3 Saudi Arabia Molecular Diagnostics Market by Application
      8.5.5.4.4 Saudi Arabia Molecular Diagnostics Market by End User
    8.5.5.5 South Africa Molecular Diagnostics Market
      8.5.5.5.1 South Africa Molecular Diagnostics Market by Product & Services
      8.5.5.5.2 South Africa Molecular Diagnostics Market by Technology
      8.5.5.5.3 South Africa Molecular Diagnostics Market by Application
      8.5.5.5.4 South Africa Molecular Diagnostics Market by End User
    8.5.5.6 Nigeria Molecular Diagnostics Market
      8.5.5.6.1 Nigeria Molecular Diagnostics Market by Product & Services
      8.5.5.6.2 Nigeria Molecular Diagnostics Market by Technology
      8.5.5.6.3 Nigeria Molecular Diagnostics Market by Application
      8.5.5.6.4 Nigeria Molecular Diagnostics Market by End User
    8.5.5.7 Rest of LAMEA Molecular Diagnostics Market
      8.5.5.7.1 Rest of LAMEA Molecular Diagnostics Market by Product & Services
      8.5.5.7.2 Rest of LAMEA Molecular Diagnostics Market by Technology
      8.5.5.7.3 Rest of LAMEA Molecular Diagnostics Market by Application
      8.5.5.7.4 Rest of LAMEA Molecular Diagnostics Market by End User

CHAPTER 9. COMPANY PROFILES

9.1 Abbott Laboratories
  9.1.1 Company Overview
  9.1.2 Financial Analysis
  9.1.3 Segmental and Regional Analysis
  9.1.4 Research & Development Expense
9.2 Qiagen N.V.
  9.2.1 Company Overview
  9.2.2 Financial Analysis
  9.2.3 Segmental and Regional Analysis
  9.2.4 Research & Development Expense
9.3 Roche Diagnostics
  9.3.1 Company Overview
  9.3.2 Financial Analysis
  9.3.3 Segmental and Regional Analysis
  9.3.4 Research & Development Expense
9.4 Grifols
  9.4.1 Company Overview
  9.4.2 Financial Analysis
  9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
  9.5.1 Company Overview
  9.5.2 Financial Analysis
  9.5.3 Segmental and Regional Analysis
  9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
  9.6.1 Company Overview
  9.6.2 Financial Analysis
  9.6.3 Segmental and Regional Analysis
  9.6.4 Research & Development Expense
9.7 Danaher Corporation
  9.7.1 Company Overview
  9.7.2 Financial Analysis
  9.7.3 Segmental and Regional Analysis
  9.7.4 Research & Development Expense

LIST OF TABLES

TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 14 GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 15 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 16 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 17 GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 18 GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 19 GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 20 GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 21 GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 22 GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 23 GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 24 GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 25 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 28 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 29 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 32 GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 33 GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 34 GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 35 GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 36 GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 37 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 38 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 39 GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 40 GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 41 GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 42 GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 43 GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 44 GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 45 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 46 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 47 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 50 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 51 GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 52 GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 53 GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 54 GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 55 GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 56 GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 57 GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 58 GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 59 GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 60 GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 61 GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 62 GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 63 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 64 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 65 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2012 - 2015, USD MILLION
TABLE 68 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2016 - 2022, USD MILLION
TABLE 69 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2012 - 2015, USD MILLION
TABLE 70 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2016 - 2022, USD MILLION
TABLE 71 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2012 - 2015, USD MILLION
TABLE 72 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2016 - 2022, USD MILLION
TABLE 73 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 74 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 75 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 80 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 81 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 82 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 83 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 84 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 85 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 86 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 87 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 88 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 89 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 90 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 91 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 92 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 93 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 94 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 95 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 96 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 97 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 98 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 99 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 100 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 101 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 102 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 103 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 104 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 105 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 106 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 107 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 108 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 109 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 110 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 111 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 112 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 113 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 114 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 115 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 116 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 117 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 118 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 119 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 120 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 121 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 122 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 123 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 124 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 125 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 126 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 127 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 128 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 129 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 130 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 131 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 132 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 133 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 134 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 135 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 136 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 137 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 138 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 139 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 140 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 141 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 142 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 143 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 144 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 145 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 146 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 147 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 148 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 149 US MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 150 US MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 151 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 152 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 153 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 154 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 155 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 156 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 157 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 158 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 159 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 160 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 161 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 162 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 163 CANADA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 164 CANADA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 165 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 166 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 167 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 168 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 169 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 170 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 171 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 172 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 173 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 174 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 175 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 176 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 177 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 178 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 179 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 180 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 181 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 182 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 183 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 184 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 185 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 186 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 187 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 188 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 189 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 190 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 191 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 192 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 193 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 194 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 195 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 196 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 197 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 198 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 199 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 200 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 201 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 202 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 203 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 204 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 205 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 206 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 207 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 208 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 209 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 210 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 211 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 212 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 213 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 214 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 215 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 216 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 217 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 218 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 219 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 220 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 221 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 222 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 223 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 224 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 225 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 226 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 227 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 228 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 229 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 230 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 231 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 232 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 233 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 234 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 235 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 236 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 237 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 238 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 239 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 240 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 241 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 242 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 243 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 244 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 245 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 246 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 247 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 248 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 249 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 250 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 251 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 252 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 253 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 254 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 255 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 256 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 257 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 258 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 259 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 260 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 261 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 262 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 263 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 264 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 265 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 266 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 267 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 268 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 269 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 270 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 271 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 272 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 273 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 274 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 275 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 276 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 277 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 278 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 279 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 280 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 281 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 282 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 283 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 284 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 285 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 286 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 287 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 288 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 289 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 290 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 291 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 292 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 293 UK MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 294 UK MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 295 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 296 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 297 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 298 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 299 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 300 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 301 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 302 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 303 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 304 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 305 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 306 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 307 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 308 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 309 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 310 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 311 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 312 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 313 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 314 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 315 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 316 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 317 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 318 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 319 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 320 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 321 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 322 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 323 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 324 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 325 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 326 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 327 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 328 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 329 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 330 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 331 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 332 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 333 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 334 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 335 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 336 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 337 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 338 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 339 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 340 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 341 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 342 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 343 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 344 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 345 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 346 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 347 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 348 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 349 ITALY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 350 ITALY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 351 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 352 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 353 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 354 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 355 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 356 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 357 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 358 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 359 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 360 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 361 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 362 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 363 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 364 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 365 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 366 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 367 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 368 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 369 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 370 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 371 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 372 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 373 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 374 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 375 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 376 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 377 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 378 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 379 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 380 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 381 ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 382 ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 383 ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 384 ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 385 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 386 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 387 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 388 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 389 ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 390 ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 391 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 392 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 393 ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 394 ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 395 ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 396 ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 397 ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 398 ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 399 ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 400 ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 401 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 402 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 403 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 404 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 405 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 406 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 407 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 408 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 409 ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 410 ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 411 ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 412 ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 413 ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 414 ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 415 ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 416 ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 417 ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 418 ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 419 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 420 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 421 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 422 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 423 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 424 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 425 ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 426 ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 427 ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 428 ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 429 ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 430 ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 431 ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 432 ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 433 ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 434 ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 435 ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 436 ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 437 ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 438 ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 439 ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 440 ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 441 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 442 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 443 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 444 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 445 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 446 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 447 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 448 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 449 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 450 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 451 CHINA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 452 CHINA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 453 CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 454 CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 455 CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 456 CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 457 CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 458 CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 459 CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 460 CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 461 CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 462 CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 463 CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 464 CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 465 JAPAN MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 466 JAPAN MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 467 JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 468 JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 469 JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 470 JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 471 JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 472 JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 473 JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 474 JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 475 JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 476 JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 477 JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 478 JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 479 INDIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 480 INDIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 481 INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 482 INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 483 INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 484 INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 485 INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 486 INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 487 INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 488 INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 489 INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 490 INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 491 INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 492 INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 493 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 494 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 495 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 496 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 497 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 498 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 499 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 500 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 501 SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 502 SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 503 SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 504 SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 505 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 506 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 507 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 508 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 509 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 510 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 511 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 512 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 513 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 514 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 515 AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 516 AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 517 AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 518 AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 519 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 520 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 521 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 522 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 523 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 524 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 525 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 526 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 527 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 528 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 529 SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 530 SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 531 SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 532 SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 533 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 534 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 535 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 536 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 537 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 538 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 539 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 540 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 541 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 542 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 543 REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 544 REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 545 REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 546 REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 547 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 548 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 549 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 550 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 551 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 552 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 553 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 554 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 555 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 556 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 557 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 558 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 559 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 560 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 561 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 562 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 563 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 564 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 565 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 566 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 567 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 568 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 569 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 570 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 571 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 572 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 573 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 574 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 575 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 576 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 577 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 578 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 579 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 580 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 581 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 582 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 583 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 584 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 585 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 586 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 587 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 588 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 589 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 590 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 591 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 592 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 593 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 594 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 595 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 596 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 597 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 598 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 599 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 600 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 601 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 602 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 603 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 604 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 605 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 606 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 607 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 608 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 609 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 610 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 611 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 612 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 613 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 614 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 615 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 616 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 617 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 618 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 619 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 620 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 621 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 622 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 623 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 624 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 625 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 626 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 627 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 628 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 629 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 630 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 631 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 632 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 633 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 634 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 635 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 636 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 637 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 638 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 639 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 640 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 641 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 642 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 643 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 644 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 645 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 646 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 647 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 648 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 649 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 650 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 651 UAE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 652 UAE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 653 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 654 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 655 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 656 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 657 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 658 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 659 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 660 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 661 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 662 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 663 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 664 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 665 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 666 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 667 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 668 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 669 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 670 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 671 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 672 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 673 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 674 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 675 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 676 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 677 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 678 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 679 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 680 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 681 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 682 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 683 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 684 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 685 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 686 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 687 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 688 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 689 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 690 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 691 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 692 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 693 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 694 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 695 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 696 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 697 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 698 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 699 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 700 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 701 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 702 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 703 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 704 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 705 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 706 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 707 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 708 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 709 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 710 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 711 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 712 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 713 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 714 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 715 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 716 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 717 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 718 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 719 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 720 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 721 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 722 KEY INFORMATION – QUIAGEN N.V.
TABLE 723 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 724 KEY INFORMATION – GRIFOLS
TABLE 725 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 726 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 727 KEY INFORMATION – DANAHER CORPORATION

Global Molecular Diagnostics Market (2016 - 2022)

More Publications

Need Help?

Ask a Question

Market Reports